By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Lysosomal enzymes > Idursulfase
Lysosomal enzymes

Idursulfase

https://themeditary.com/drug/idursulfase-6252.html
Medically Reviewed by Glamora Samuels, MD TheMediTary.Com | Reviewed: Aug 13, 2023  Additional Content by TheMediTary.Com

Generic name: idursulfase [ eye-dur-sul-fase ]

Drug class: Lysosomal enzymes

Dosage form: intravenous solution (2 mg/ml)

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Elaprase

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Idursulfase?

Idursulfase contains a natural enzyme that some people lack because of a genetic disorder. Idursulfase helps replace this missing enzyme.

Idursulfase is used to treat some of the symptoms of a genetic condition called Hunter's syndrome, also called mucopolysaccharidosis (MYOO-koe-pol-ee-SAK-a-rye-DOE-sis).

Hunter syndrome is a metabolic disorder in which the body lacks the enzyme needed to break down certain natural substances. These substances can build up in the body, causing enlarged organs, abnormal bone structure, changes in facial features, breathing problems, heart problems, vision loss, and changes in mental or physical abilities.

Idursulfase may improve walking ability in people with this condition. However, this medication is not a cure for Hunter syndrome.

Idursulfase may also be used for purposes not listed in this medication guide.

Warnings

Some side effects may occur during the idursulfase infusion, or up to 24 hours afterward. Get emergency medical help if you have signs of an allergic reaction: feeling like you might pass out; hives; trouble breathing; seizure (convulsions); swelling of your face, lips, tongue, or throat.

How should I take Idursulfase

Idursulfase is given as an infusion into a vein. A healthcare provider will give you this injection, usually once per week.

This medicine must be given slowly, and the infusion can take up to 3 hours to complete.

Your doctor may also prescribe other medications to help prevent an allergic reaction to idursulfase. Take all of your medications as directed.

Your doctor will need to check your progress on a regular basis.

Dosing information

Usual Adult Dose for Mucopolysaccharidosis Type II:

0.5 mg/kg IV once a week

Comment:
-Clinical studies did not include patients older than 31 years and it is therefore unknown if they respond differently than younger patients.

Use: For the treatment of Hunter syndrome (Mucopolysaccharidosis II [MPS II])

Usual Pediatric Dose for Mucopolysaccharidosis Type II:

16 months or older:
0.5 mg/kg IV once a week

Use: For the treatment of Hunter syndrome (MPS II)

Detailed Idursulfase dosage information
Idursulfase Dosage information (more detail)

Before Taking

You should not receive this medication if you are allergic to idursulfase.

Tell your doctor if you have asthma or any other lung problems. An allergic reaction could trigger sudden breathing problems.

Your name may be listed on a Hunter Outcome Survey while you are using this medication. The purpose of this registry is to track the progression of this disorder and the effects that idursulfase has on long-term treatment.

It is not known whether idursulfase will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

It may not be safe to breast-feed a baby while you are using this medicine. Ask your doctor about any risks.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your idursulfase injection.

What happens if I overdose?

Since idursulfase is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

What should I avoid while using Idursulfase?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Idursulfase side effects

Some side effects may occur during the idursulfase infusion, or up to 24 hours afterward. Get emergency medical help if you have signs of an allergic reaction: feeling like you might pass out; hives; trouble breathing, seizure (convulsions); swelling of your face, lips, tongue, or throat.

If you ever have an allergic reaction to idursulfase, you will be watched closely after receiving idursulfase again.

Common side effects of idursulfase may include:

  • vomiting, diarrhea;

  • headache;

  • muscle or joint pain;

  • fever, cough;

  • itching, rash; or

  • flushing (warmth, redness, or tingly feeling).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Idursulfase Side Effects

More about Idursulfase (Idursulfase [ eye-dur-sul-fase ])

Dosage information
Idursulfase Side Effects
During pregnancy
Drug images
Side effects
Breastfeeding Warnings
Drug class: Lysosomal enzymes

Related treatment guides

Mucopolysaccharidosis Type II
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by